![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 31, 2020 7:51:22 PM
The question I posted is
"Assuming the company knew its DCVax-L trial failed in terms of its primary endpoint in Nov, would the public have been notified by now more than a month after the company knew its trial failed in its primary endpoint? "
What's your answer Doc?
You should understand nobody relies his/her investment on that so-called "4-day rule," and whether it's applicable here or not is not the issue, but no one should deny it's a one more layer of insurance besides the rock-solid science and the blinded data we have known for the trial (if your answer is yes to the question above of course).
You know the company announced data lock around 5 October, today is 31 December. Any reasonable person would assume the company (at least Linda) has been unblinded for a quite while, probably at least more than a month.
Now back to the question, if the trial failed in terms of its primary endpoint according to the revised SAP, do you think the company would keep it from the public for more than a month, or two weeks, or two months, or a week?
Because we know the foundation of the science behind the trial and the blinded data, we pretty much are assure that the primary endpoint would be readily met in a statistically significant way, hence a reasonable person with the above knowledge would not think the trial would fail in terms of its primary endpoint, and hence no news is good news as of today, and hence we have one more layer of insurance in our investment, unless you think Linda and/or Les are crooks.
Now somebody seemingly for purely argument purpose has persistently "denied" the very high probability that the trial is at least a success in terms of meeting its primary endpoint, by "arguing endlessly at any chance on whether there is a 4-day rule or whether such a rule is appropriate for TLD release. In doing so, he/she gives an impression for newbies that the trail is still very likely a failure in terms of not meeting its primary endpoint according to the revised SAP.
That's the problem Doc. You may have been used to the very busy ER working environment, and it's hard for you to sink in. That's okay. We all have problem understanding things correctly sometimes.
On the other hand, you should also realize you are in no position to judge as you seems to be a person who is easy to be carried away by something superficial. Seemingly eloquent talking with false/misleading information is nothing more than a nice clothing doc.
Happy New Year!
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM